Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | Director | Common Stock | 2.5K | $137K | $54.75 | Jun 26, 2024 | Direct |
CONCERT PHARMACEUTICALS, INC. | Director | Common Stock | 5.13K | $42.7K | $8.33 | Jun 10, 2021 | Direct |
CONCERT PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 10.3K | Jun 10, 2021 | Direct | ||
Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 8.35K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JANX | Janux Therapeutics, Inc. | Jun 26, 2024 | 2 | $0 | 4 | Jun 28, 2024 | Director |
JANX | Janux Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
JANX | Janux Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
JANX | Janux Therapeutics, Inc. | Sep 7, 2021 | 1 | $0 | 4 | Sep 9, 2021 | Director |
JANX | Janux Therapeutics, Inc. | Sep 7, 2021 | 0 | $0 | 3 | Sep 9, 2021 | Director |
CNCE | CONCERT PHARMACEUTICALS, INC. | Jun 10, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |